Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire November 07, 2025 CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.(R) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock […]

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire November 07, 2025 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on November 3, 2025 (the “Grant

Cannabix Technologies announces Non-Brokered LIFE Private Placement

Cannabix Technologies announces Non-Brokered LIFE Private Placement GlobeNewswire November 07, 2025 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORFOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 07, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (the “Company or Cannabix”) announces a non-brokered private placement for a minimum of 2,127,659 units

Ultralife Corporation Files Form 12b-25 Notification of Late Filing

Ultralife Corporation Files Form 12b-25 Notification of Late Filing GlobeNewswire November 07, 2025 NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended

Cornerstone Funds Announce Continuing Monthly Distributions and Reset Distribution Amounts for 2026

Cornerstone Funds Announce Continuing Monthly Distributions and Reset Distribution Amounts for 2026 GlobeNewswire November 07, 2025 NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) — Cornerstone Strategic Investment Fund, Inc. (NYSE American: CLM) (CUSIP: 21924B302) and Cornerstone Total Return Fund, Inc. (NYSE American: CRF) (CUSIP: 21924U300), (individually the “Fund” or, collectively, the “Funds”), each a closed-end

Canadian Investment Regulatory Organization Trading Halt – INXD

The following issues have been halted by CIRO: Company: The INX Digital Company Inc. Cboe CA Exchange Symbol : INXD All Issues: Yes Reason: Pending Delisting Halt Time (ET): 4:00 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented

Denver Arts Week Kicks Off with More Than 700 Events Across the City

The ten-day celebration highlights the Mile High City's vibrant and diverse arts and culture scene Today is the first of a ten-day celebration of Denver's arts and culture, encompassing 700 events and ways to celebrate art, representing over 250 individual organizations across the city. Recognized for its creative energy and thriving cultural scene, Denver will

Halper Sadeh LLC Encourages CIVI, QRVO, CCRD Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: https://mma.prnewswire.com/media/1896150/Firm_Logo_with_Investor_Law_Firm_Logo.jpg Civitas Resources, Inc. (NYSE: CIVI)'ssale to SM Energy

/U P D A T E — MediPharm Labs Corp./

In the news release, MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders, issued 13-May-2025 by MediPharm Labs Corp. over PR Newswire, please be advised that updates have been made throughout the release and will replace the prior version in full: MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders MediPharm Labs Corp.

Trinity Bank Reports 2025 3rd Quarter Net Income Of $2,324,000

3RD QUARTER RETURN ON ASSETS 1.70% 3RD QUARTER RETURN ON EQUITY 14.35% FORT WORTH, TX / ACCESS Newswire / November 7, 2025 / Trinity Bank, N.A. (OTC PINK:TYBT) today announced operating results for the third quarter and the nine months ending September 30, 2025. Results of Operation For the third quarter 2025, Trinity Bank, N.A.

Scroll to Top